CLIK
Home > SOP Information > SOPs and Supporting Information – alphabetic listing > M > Malignant Neoplasm of the Renal Pelvis and Ureter B044

Malignant Neoplasm of the Renal Pelvis and Ureter B044

Last amended 
Monday, October 14, 2019
Current RMA Instruments
Reasonable Hypothesis SOP [1]

92 of 2019 

Balance of Probabilities SOP [2]93 of 2019 
Changes from previous Instruments

SOP bulletin 211 [3]

ICD Coding
  • ICD-9-CM Codes: 189.1,189.2
  • CD-10-AM Codes: C65, C66, C07
Brief description

This is a primary cancer of the renal pelvis (the structure that collects urine from the kidney and funnels it into the ureter), or the ureter (the tube that connects the kidney to the bladder). 

Confirming the diagnosis

The diagnosis requires confirmation by histology.

The relevant medical specialist is a urologist.

Additional diagnoses covered by SOP
  • Adenocarcinoma of the renal calyx, renal pelvis, pelviureteric junction or ureter
  • Neuroendocrine carcinoma (including malignant carcinoid) of the renal calyx, renal pelvis, pelviureteric junction or ureter
  • Squamous cell carcinoma of the renal calyx, renal pelvis, pelviureteric junction or ureter
  • Carcinoma in situ of the renal calyx, renal pelvis, pelviureteric junction or ureter
  • Carcinoma of the renal calyx, renal pelvis, pelviureteric junction or ureter
  • Transitional cell carcinoma of the renal calyx, renal pelvis, pelviureteric junction or ureter
Related conditions that may be covered by SOP (further information required)
  • Cancer of the renal pelvis, renal calyx or ureter
  • Renal pelvic and ureteric cancer
Conditions not covered by SOP
  • Hodgkin’s lymphoma of the renal calyx, pelvis or ureter* 
  • Malignant neoplasm of ureteric orifice of bladder* (malignant neoplasm of the bladder SOP)
  • Non-Hodgkin lymphoma of the renal calyx, pelvis or ureter*
  • Secondary/metastatic cancer involving the renal calyx, pelvis or ureter (code to primary site)
  • Soft-tissue sarcoma of the renal calyx, pelvis or ureter*

* another SOP applies

Clinical onset

The most common presentation is with haematuria (blood in the urine).  Flank pain may also occur.  Clinical onset will often be based on the first relevant symptoms.  The condition may also be found incidentally, e.g., following radiological imaging or cystoscopy with ureteropyeloscopy for investigation of a bladder condition.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  The condition has a variable course and prognosis.  It is amenable to treatment if found early.  A delay in appropriate treatment could result in worsening of the condition.  Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.

 

 

Rulebase for malignant neoplasm of the renal pelvis and ureter

  • Log in [4] to post comments

Place holder node for Rulebase for malignant neoplasm of the renal pelvis and ureter

Cigar smoking

Malignant neoplasm of the renal pelvis and ureter - Cigar smoking Factor

Last reviewed for CCPS 30 June 1999.

Investigative Documents

Claimant Report - Smoking [CRD905]

[5] Claimant Report - Smoking [CRV905]

Preliminary questions [23643]

[6]22889

there is some evidence that cigar smoking may be a factor in the development of the condition under consideration.

23645 — the veteran has established the causal connection between the cigar smoking and VEA service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

23646 — the veteran has established the causal connection between the cigar smoking and operational service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

or

23647 — the veteran has established the causal connection between the cigar smoking and eligible service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

Clinical onset and operational service [23646]

23648 — the veteran has smoked at least five pack years of cigars at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter. [7]

4921 — the veteran has some period or periods of cigar smoking that are causally related to operational service. [8]

Clinical onset and eligible service [23647]

23649 — the veteran has smoked at least ten pack years of cigars at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter. [9]

4922 — the veteran has some period or periods of cigar smoking that are causally related to eligible service. [10]

Cigarette smoking

Malignant neoplasm of the renal pelvis and ureter - Cigarette smoking Factor

Last reviewed for CCPS 30 June 1999.

Investigative Documents

Claimant Report - Smoking [CRD905]

[5] Claimant Report - Smoking [CRV905]

Preliminary questions [23634]

[11]5803

the veteran has ever smoked cigarettes. [12]

23636 — the veteran has established the causal connection between the cigarette smoking and VEA service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

23639 — the veteran has established the causal connection between the cigarette smoking and operational service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

or

23640 — the veteran has established the causal connection between the cigarette smoking and eligible service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

Clinical onset and operational service [23639]

23641 — the veteran has smoked at least five pack years of cigarettes at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter. [13]

3116 — the veteran has some period or periods of cigarette smoking that are causally related to operational service. [14]

Clinical onset and eligible service [23640]

23642 — the veteran has smoked at least ten pack years of cigarettes at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter. [15]

3521 — the veteran has some period or periods of cigarette smoking that are causally related to eligible service. [16]

Injection with thorotrast

Malignant neoplasm of the renal pelvis and ureter - Injection with thorotrast Factor

Last reviewed for CCPS 30 June 1999.

Preliminary questions [23675]

23676 [17] there is some evidence that an intravascular or intracavital injection of thorotrast may be a factor in the development of the condition under consideration.

20665 [17] the veteran has had an intravascular or intracavital injection of thorotrast at some time.

23677 [18] the veteran has had an intravascular or intracavital injection of thorotrast to the abdominal or pelvic organs at some time.

[19]23678

the veteran has had an intravascular injection of thorotrast or an intracavital injection of thorotrast to the abdominal or pelvic organs before the clinical onset of malignant neoplasm of the renal pelvis and ureter.

23679 — the veteran has established the causal connection between the injection with thorotrast and VEA service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

23680 — the veteran has established the causal connection between the injection with thorotrast and operational service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

or

23681 — the veteran has established the causal connection between the injection with thorotrast and eligible service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

Clinical onset and operational service [23680]

[20]24144

on operational service, the veteran had an intravascular or intracavital injection of thorotrast to the abdominal or pelvic organs before the clinical onset of the condition under consideration.

[21]25077

the intravascular or intracavital injection of thorotrast to the abdominal or pelvic organs on operational service before the clinical onset of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[22]20675

the veteran has had an intravascular or intracavital injection of thorotrast to the abdominal or pelvic organs before the clinical onset of the condition under consideration for treatment of an illness or injury which is identifiable.

20676 — the identified illness or injury for which the intravascular or intracavital injection of thorotrast to the abdominal or pelvic organs was given is causally related to operational service. [23] [24]

Clinical onset and eligible service [23681]

[25]20675

the veteran has had an intravascular or intracavital injection of thorotrast to the abdominal or pelvic organs before the clinical onset of the condition under consideration for treatment of an illness or injury which is identifiable. [23]

20677 — the identified illness or injury for which the intravascular or intracavital injection of thorotrast to the abdominal or pelvic organs was given is causally related to eligible service. [26] [24]

No appropriate clinical management for neoplasm of renal pelvis and ureter

Malignant neoplasm of the renal pelvis and ureter - No appropriate clinical management for neoplasm of renal pelvis and ureter Factor

Last reviewed for CCPS 30 June 1999.

Investigative Documents

Medical Report - Inability to Obtain Appropriate Clinical Management - [GQACM]

Preliminary questions [23683]

11109 — the condition under consideration has been accepted on the basis of inability to obtain appropriate clinical management for the condition under consideration.

[27]7066

there is some evidence that an inability to obtain appropriate clinical management for the condition under consideration may be a factor in the worsening of the condition under consideration.

7334 [28] the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

[29]7335

the condition under consideration permanently worsened.

[30]7378

the veteran was unable to obtain appropriate clinical management for the condition under consideration at some time.

7379 [31] the inability to obtain appropriate clinical management for the condition under consideration contributed to the clinical worsening of the condition under consideration.

11234 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and VEA service for the clinical worsening of the condition under consideration.

11235 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and operational service for the clinical worsening of the condition under consideration.

or

11236 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and eligible service for the clinical worsening of the condition under consideration.

Clinical worsening and operational service [11235]

[32]7384

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during operational service.

[33]21084

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during operational service, as a causal result of operational service.

[34]7387

the veteran's inability to obtain appropriate clinical management for the condition under consideration during operational service was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[22]7389

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, because of an illness or injury which is identifiable.

7390 — the identified illness or injury which prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related to operational service. [35] [36]

[37]7392

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related.

Clinical worsening and eligible service [11236]

[38]7385

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during eligible service.

[39]7386

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during eligible service, as a causal result of eligible service.

[40]7388

the veteran's inability to obtain appropriate clinical management for the condition under consideration during eligible service was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[22]7389

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, because of an illness or injury which is identifiable.

7391 — the identified illness or injury which prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related to eligible service. [35] [36]

[41]7393

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related. [42]

Phenacetin consumption

Malignant neoplasm of the renal pelvis and ureter - Phenacetin consumption Factor

Last reviewed for CCPS 30 June 1999.

Investigative Documents

Claimant Report - Phenacetin - Malignant Neoplasm of the Renal Pelvis and Ureter [CR9115]

[43] Medical Report - Phenacetin - Malignant Neoplasm of the Renal Pelvis and Ureter [MR9148]

Preliminary questions [23657]

[44]23658

the veteran has consumed phenacetin in phenacetin containing preparations at some time.

23659 — the veteran has established the causal connection between the consumption of phenacetin in phenacetin containing preparations and VEA service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

23660 — the veteran has established the causal connection between the consumption of phenacetin in phenacetin containing preparations and operational service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

or

23661 — the veteran has established the causal connection between the consumption of phenacetin in phenacetin containing preparations and eligible service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

Clinical onset and operational service [23660]

[45]23662

the veteran consumed a total of 50 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration.

[46]23705

the veteran's consumption of a total of 50 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration was materially contributed to by treatment of an illness or injury which is identifiable.

23667 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin containing preparations, is causally related to operational service. [47] [48]

Clinical onset and eligible service [23661]

[49]23668

the veteran consumed a total of 100 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration.

[50]23705

the veteran's consumption of a total of 50 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration was materially contributed to by treatment of an illness or injury which is identifiable.

[47]23672

the identified illness or injury made a material contribution to the veteran's consumption of a total of 100 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration. [51]

23674 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin containing preparations, is causally related to eligible service. [52] [48]

Pipe smoking

Malignant neoplasm of the renal pelvis and ureter - Pipe smoking Factor

Last reviewed for CCPS 30 June 1999.

Investigative Documents

Claimant Report - Smoking [CRD905]

[5] Claimant Report - Smoking [CRV905]

Preliminary questions [23650]

[53]22895

there is some evidence that pipe smoking may be a factor in the development of the condition under consideration.

23652 — the veteran has established the causal connection between the pipe smoking and VEA service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

23653 — the veteran has established the causal connection between the pipe smoking and operational service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

or

23654 — the veteran has established the causal connection between the pipe smoking and eligible service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

Clinical onset and operational service [23653]

23655 — the veteran has smoked at least five pack years of pipe tobacco at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter. [54]

4911 — the veteran has some period or periods of pipe smoking that are causally related to operational service. [55]

Clinical onset and eligible service [23654]

23656 — the veteran has smoked at least ten pack years of pipe tobacco at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter. [56]

4913 — the veteran has some period or periods of pipe smoking that are causally related to eligible service. [57]

Smoking tobacco products - material contribution

Malignant neoplasm of the renal pelvis and ureter - Smoking tobacco products - material contribution Factor

Last reviewed for CCPS 30 June 1999.

Investigative Documents

Claimant Report - Smoking [CRD905]

[5] Claimant Report - Smoking [CRV905]

Preliminary questions [35626]

[58]30303

the veteran has smoked cigarettes, cigars or pipe tobacco at some time.

35627 — the veteran has established the causal connection between smoking tobacco products and VEA service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

35628 — the veteran has established the causal connection between smoking tobacco products and operational service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

or

35629 — the veteran has established the causal connection between smoking tobacco products and eligible service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

Clinical onset and operational service [35628]

[59]35630

the veteran has smoked at least five pack years of cigarettes or the equivalent thereof in other tobacco products at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter.

[60]35632

smoking as a causal result of operational service made a material contribution to the SOP requirements for malignant neoplasm of the renal pelvis and ureter and smoking tobacco products.

Clinical onset and eligible service [35629]

[61]35631

the veteran has smoked at least ten pack years of cigarettes or the equivalent thereof in other tobacco products at least ten years before the clinical onset of malignant neoplasm of the renal pelvis and ureter.

[62]35633

smoking as a causal result of eligible service made a material contribution to the SOP requirements for malignant neoplasm of the renal pelvis and ureter and smoking tobacco products. [63]


Source URL (modified on 20/11/2019 - 9:02am): https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-renal-pelvis-and-ureter-b044-c65c66

Links
[1] http://www.rma.gov.au/assets/SOP/2019/c927871f23/092.pdf
[2] http://www.rma.gov.au/assets/SOP/2019/d0dc4faf39/093.pdf
[3] https://clik.dva.gov.au/system/files/media/SOP%20bulletin%20211_0.pdf
[4] https://clik.dva.gov.au/user/login?destination=comment/reply/63808%23comment-form
[5] https://clik.dva.gov.au/ccpsclaimant-115
[6] clikpopup://CCPS/Cigar smoking
[7] clikpopup://CCPS/reject23648No
[8] clikpopup://CCPS/reject4921No
[9] clikpopup://CCPS/reject23649No
[10] clikpopup://CCPS/reject4922No
[11] clikpopup://CCPS/Cigarette smoking
[12] clikpopup://CCPS/reject5803No
[13] clikpopup://CCPS/reject23641No
[14] clikpopup://CCPS/reject3116No
[15] clikpopup://CCPS/reject23642No
[16] clikpopup://CCPS/reject3521No
[17] https://clik.dva.gov.au/ccpsb044rc
[18] clikpopup://CCPS/Injection with thorotrast to the abdominal or pelvic organs at some time
[19] clikpopup://CCPS/reject23677No
[20] clikpopup://CCPS/reject23678No
[21] clikpopup://CCPS/reject24144No
[22] clikpopup://CCPS/rejectwilful
[23] clikpopup://CCPS/reject20675No
[24] clikpopup://CCPS/reject20676,20677No
[25] clikpopup://CCPS/Injection with thorotrast before onset of mn renal pelvis and ureter for illness or injury
[26] clikpopup://CCPS/reject20677No
[27] https://clik.dva.gov.au/ccpsother-31
[28] https://clik.dva.gov.au/node/71191
[29] clikpopup://CCPS/Reject/OnsetAfterService
[30] clikpopup://CCPS/Reject/NoPermanentWorsening
[31] clikpopup://CCPS/MN renal pelvis and ureter/ACM - contributed to worsening
[32] clikpopup://CCPS/ACM/NoContribution
[33] clikpopup://CCPS/ACM/NotOpService
[34] clikpopup://CCPS/ACM/NotOperDuties
[35] clikpopup://CCPS/ACM/NoIllness
[36] clikpopup://CCPS/reject7390,7391No
[37] clikpopup://CCPS/MN renal pelvis and ureter/ACM - onset prior to operational service
[38] clikpopup://CCPS/ACM/OnsetFailOper
[39] clikpopup://CCPS/ACM/NotEligService
[40] clikpopup://CCPS/ACM/NotEligDuties
[41] clikpopup://CCPS/MN renal pelvis and ureter/ACM - onset prior to eligible service
[42] clikpopup://CCPS/ACM/OnsetFailElig
[43] https://clik.dva.gov.au/ccpsclaimant-161
[44] clikpopup://CCPS/Consumed phenacetin in phenacetin containing preparations at some time
[45] clikpopup://CCPS/reject23658No
[46] clikpopup://CCPS/reject23662No
[47] clikpopup://CCPS/reject23705No
[48] clikpopup://CCPS/reject23667,23674No
[49] clikpopup://CCPS/Consumed 100 grams of phenacetin 10 years before onset of mn renal pelvis and ureter
[50] clikpopup://CCPS/reject23668No
[51] clikpopup://CCPS/reject23672No
[52] clikpopup://CCPS/reject23674No
[53] clikpopup://CCPS/Pipe smoking
[54] clikpopup://CCPS/reject23655No
[55] clikpopup://CCPS/reject4911No
[56] clikpopup://CCPS/reject23656No
[57] clikpopup://CCPS/reject4913No
[58] clikpopup://CCPS/Smoked cigarettes, pipe tobacco or cigars at some time
[59] clikpopup://CCPS/reject30303No
[60] clikpopup://CCPS/reject35630No
[61] clikpopup://CCPS/reject35632No
[62] clikpopup://CCPS/reject35631No
[63] clikpopup://CCPS/reject35633No